Markets:

Overview

News

Currencies

International

Treasuries

Omeros Corporation - Common Stock (NQ:OMER)

18.80 -0.08 (-0.45%)

Delayed Quote Updated: 2:37 PM EDT, Oct 14, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Omeros Corporation - Common Stock

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

Omeros Corporation Reports Third Quarter 2021 Financial Results

November 09, 2021

From Omeros Corporation

Via Business Wire

The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data ↗

November 09, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Gets Antitrust Nod For Acceleron Deal In Germany, Austria, Announces...

Via Benzinga

Earnings Outlook For Omeros ↗

November 08, 2021

Omeros (NASDAQ:OMER) is set to give its latest quarterly earnings report on Tuesday, 2021-11-09. Here's what investors need to know before the announcement. Analysts estimate that...

Via Benzinga

Omeros' Narsoplimab Shows Improved, Stabilized Renal Function At Three Years ↗

November 05, 2021

Omeros Corporation (NASDAQ: OMER) announced long-term follow-up (35 months) results from the Phase 2 trial of its MASP-2 inhibitor narsoplimab in patients with IgA...

Via Benzinga

Omeros Announces Results From Nearly Three-Year Follow-up of Patients in Phase 2 IgA Nephropathy Trial

November 05, 2021

From Omeros Corporation

Via Business Wire

Omeros’ Narsoplimab Stabilized Kidney Function and Reduced Urinary Complement Proteins in a Patient with IgA Vasculitis

November 05, 2021

From Omeros Corporation

Via Business Wire

Omeros Corporation to Announce Third Quarter Financial Results on November 9, 2021

November 04, 2021

From Omeros Corporation

Via Business Wire

Attention Biotech Investors: Mark Your Calendar For November PDUFA Dates ↗

November 02, 2021

The loaded Prescription Drug User Fee Act (PDUFA) calendar for October produced mixed outcomes. PDUFA dates are key binary events for biotech stocks that can move the needle in a...

Via Benzinga

3 Beaten-Down Biotech Stocks -- Can They Recover? ↗

October 31, 2021

Each for reasons of their own, Atea Pharmaceuticals, Omeros, and Novavax have had a very tough time this year.

Via The Motley Fool

NASDAQ:OMER Investor Notice: Investigation over Possible Securities Laws Violations by Omeros Corporation ↗

October 22, 2021

San Diego, CA -- (SBWIRE) -- 10/22/2021 -- An investigation was announced concerning potential securities laws violations by Omeros Corporation in connection with certain financial statements.

Via SBWire

10 Biggest Price Target Changes For Tuesday ↗

October 19, 2021

Goldman Sachs boosted Walmart Inc. (NYSE:WMT) price...

Via Benzinga

46 Biggest Movers From Yesterday ↗

October 19, 2021

Gainers Valneva SE (NASDAQ: VALN) shares surged 39.8% to close at $39.21 on Monday after the company reported VLA2001 met both co-primary endpoints in the Phase 3 pivotal trial...

Via Benzinga

Omeros Stock Falls As FDA Asks For More Clinical Narsoplimab Data In HSCT-TMA ↗

October 18, 2021

The FDA issued a Complete Response Letter (CRL) related to Omeros Corporation's (NASDAQ: OMER) marketing application for narsoplimab for hematopoietic...

Via Benzinga

Mid-Afternoon Market Update: Dow Falls 70 Points; Evolving Systems Shares Spike Higher ↗

October 18, 2021

Toward the end of trading Monday, the Dow traded down 0.20% to 35,223.86 while the NASDAQ rose 0.68% to 14,998.54. The S&P also rose, gaining 0.19% to 4,480.05. The U.S. has...

Via Benzinga

Topics Stocks

Benchmarks Pare Losses on Upbeat Earnings Outlook ↗

October 18, 2021

The major benchmarks are paring earlier losses at midday, fresh off of their best week in months as earnings season kicks off.

Via Talk Markets

12 Health Care Stocks Moving In Monday's Intraday Session ↗

October 18, 2021

Gainers Progenity (NASDAQ:PROG) shares increased by 33.17% to $2.85 during Monday's regular session. As of 12:30 EST, Progenity's stock is trading at a volume of...

Via Benzinga

Mid-Day Market Update: Nasdaq Rises 50 Points; Revance Therapeutics Shares Plummet ↗

October 18, 2021

Midway through trading Monday, the Dow traded down 0.05% to 35,275.96 while the NASDAQ rose 0.34% to 14,948.46. The S&P also rose, gaining 0.19% to 4,479.71. The U.S. has the...

Via Benzinga

Topics Stocks

Here's Why Omeros Is Sinking Further Today ↗

October 18, 2021

Bad news the company received today from the FDA surprised investors more than it probably should have.

Via The Motley Fool

34 Stocks Moving In Monday's Mid-Day Session ↗

October 18, 2021

Gainers Valneva SE (NASDAQ: VALN) shares jumped 34.6% to $37.75 after the company reported VLA2001 met both co-primary endpoints in the Phase 3 pivotal trial Cov-Compare....

Via Benzinga

Mid-Morning Market Update: Markets Mostly Lower; Albertsons Tops Q2 Estimates ↗

October 18, 2021

Following the market opening Monday, the Dow traded down 0.32% to 35,182.99 while the NASDAQ rose 0.12% to 14,915.84. The S&P also fell, dropping 0.06% to 4,468.81. The U.S....

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

October 18, 2021

Gainers Valneva (NASDAQ:VALN) stock increased by 35.65% to $38.05 during Monday's pre-market session. The market value of their outstanding shares is at $1.8 billion....

Via Benzinga

Omeros Receives Complete Response Letter from FDA for Biologics License Application for Narsoplimab in the Treatment of HSCT-TMA

October 18, 2021

From Omeros Corporation

Via Business Wire

35 Biggest Movers From Friday ↗

October 11, 2021

Gainers ChemoCentryx, Inc. (NASDAQ: CCXI) shares surged 96% to close at $38.41 on Friday. The FDA approved ChemoCentryx’s Tavneos (avacopan) as an adjunctive treatment for...

Via Benzinga

The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology ↗

October 12, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 11) AstraZeneca Plc (NASDAQ:...

Via Benzinga

28 Stocks Moving In Friday's Mid-Day Session ↗

October 08, 2021

Gainers ChemoCentryx, Inc. (NASDAQ: CCXI) shares climbed 60.8% to $31.51. The FDA approved ChemoCentryx’s Tavneos (avacopan) as an adjunctive treatment for anti-neutrophil...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 8, 2021 ↗

October 08, 2021

Upgrades UBS upgraded the previous rating for Northern Trust Corp (NASDAQ:

Via Benzinga

OMEROS ALERT: Bragar Eagel & Squire, P.C. is Investigating Omeros Corporation on Behalf of Omeros Stockholders and Encourages Investors to Contact the Firm

October 07, 2021

From Bragar Eagel & Squire, P.C.

Via Business Wire

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Omeros Corporation (OMER) on Behalf of Investors

October 06, 2021

From Glancy Prongay & Murray LLP

Via Business Wire

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Omeros Corporation (OMER) on Behalf of Investors

October 05, 2021

From Law Offices of Howard G. Smith

Via Business Wire

The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal ↗

October 06, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 5) Bicycle Therapeutics plc (...

Via Benzinga

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Omeros Corporation - Common Stock (NQ:OMER)

All News about Omeros Corporation - Common Stock

Starting at /week.